YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)

Rhabdomyolysis


AddThis Social Bookmark Button

Rhabdomyolysis

Rhabdomyolysis is a serious disorder that causes kidney damage resulting from toxic effects of the contents of muscle cells. Myoglobin is an iron-containing pigment found in the skeletal muscle. When the skeletal muscle is damaged, the myoglobin is released into the bloodstream. It is filtered out of the bloodstream by the kidneys. Myoglobin may obstruct the structures of the kidney, causing damage such as acute tubular necrosis or kidney failure.

Myoglobin breaks down into potentially toxic compounds, which will also cause kidney failure. It is important to treat Rhabdomyolysis quickly. Early and aggressive hydration may prevent complications by rapidly eliminating the myoglobin out of the kidneys. The hydration needs with muscle necrosis may approximate the massive fluid volume needs of a severely burned patient. This may involve intravenous administration of several liters of fluid until the condition stabilizes.

Diuretic medications such as mannitol or furosemide may aid in flushing the pigment out of the kidneys. If the urine output is sufficient, bicarbonate may be given to maintain an alkaline urine state. This helps to prevent the dissociation of myoglobin into toxic compounds.

Rhabdomyolysis results from any condition that causes significant muscle damage. These include:
  • Certain muscle diseases
  • Severe muscle injuries (e.g., crush injury)
  • Overuse of alcohol or illicit drugs
  • Use of some prescription drugs
  • Severe seizures or convulsions

If you or a loved one has taken the Statin drugs, Baycol or Crestor and have been diagnosed with Rhabdomyolysis, please fill out the form at the right for a free case evaluation by a qualified defective drug attorney.

RhabdomyolysisRSS Feed

Simvastatin and Amiodarone Linked to Possibly Fatal Muscle Disease

Aug 8, 2008 | Parker Waichman Alonso LLP
The combination of simvastatin and amiodarone, an anti-arrhythmia medication, has been linked to a rare muscle condition that can cause kidney damage and death.  The Food & Drug Administration (FDA) first warned against combining the drugs in 2002 because of their association with the condition - called rhabdomyolysis -  but has continued to received reports of its occurrence.Amiodarone is an ingredient in Wyeth's Cordarone and is also sold generically. Simvastatin is an...

Report: Bayer Held Back on Drug Dangers

Nov 23, 2004 | Los Angeles Times
Another pharmaceutical company may have concealed safety information about a dangerous drug this time Bayer and its once-popular cholesterol medication Baycol according to a report in a prominent medical journal.Baycol was pulled from the market in 2001, but an analysis released Monday by the Journal of the American Medical Assn. argued there were strong indications of its dangers three months after its introduction in 1998.The report adds to concerns that the Food and Drug Administration's...

Advocate Suggests Crestor May Harm Kidneys

Oct 29, 2004 | AP
Consumer advocate Dr. Sidney Wolfe renewed his effort Friday to get the anti-cholesterol drug Crestor removed from sale. Wolfe sent a letter to the Food and Drug Administration citing 29 cases of kidney problems 18 of kidney failure and 11 of kidney insufficiency out of some 4.5 million prescriptions for the drug between Jan. 1, 2001 and Sept. 30, 2003. That is more kidney problems than reported by all other statin-type anti-cholesterol drugs, Wolfe said. Emily Denney, a spokesperson for...

Rate of Kidney Damage in Crestor Patients Is 75 Times Higher Than in Patients Taking Other Cholesterol Drugs

Oct 29, 2004 | www.PharmaLive.com
The rate of reports of kidney failure or damage among patients taking the cholesterol drug Crestor is 75 times higher than in all patients taking all other statins, according to a Public Citizen analysis of government data. Public Citizen sent the information today to the U.S. Food and Drug Administration and renewed its call for the drug to be taken off the market.It becomes clearer by the day that this drug is uniquely toxic but offers no unique benefit, and must be removed from the market,...

Dear Dr. Crawford

Oct 29, 2004 | www.citizen.org
Lester Crawford, DVM, Acting CommissionerFood and Drug Administration5600 Fishers LaneRockville, MD 20854Dear Dr. Crawford,We have just completed an analysis of the FDAs adverse drug reaction database (AERS) and have found that the rate of reports to the FDA of acute renal failure or renal insufficiency per million prescriptions in patients using rosuvastatin (Crestor)29 U.S. reports in less than one year since the drug was first marketed in this country is approximately 75 times higher than...

More Rhabdomyolysis News

Rhabdomyolysis
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

If you believe Rhabdomyolysis is due to a cholesterol drug, please list drug:

Please describe your case:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Contact
Statement of Clients' Rights | Site Map | ReNu with MoistureLoc | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome

© 2002-2008 YourLawyer.com. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News